Plasma glucose-lowering effect of β-endorphin in streptozotocin-induced diabetic rats

Hormone and Metabolic Research

Volumn 34, Issue 10, 2002, Pages 570-576

  Cheng, J T ^a   Liu, I M ^a,b   Tzeng, T F ^c   Tsai, C C ^d   Lai, T Y ^d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Endorphin; Hepatocytes; Opioid Receptors; Phospholipase C; Protein Kinase C; Soleus Muscle

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ANTIDIABETIC AGENT; BETA ENDORPHIN; CHELERYTHRINE; GLUCOSE; GLYCOGEN; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; U 73312; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ENZYME INHIBITOR; NARCOTIC ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; IN VITRO STUDY; METABOLISM; SKELETAL MUSCLE; WISTAR RAT;

ANIMALIA;

ANIMALS; BETA-ENDORPHIN; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUCOSE; HEPATOCYTES; MALE; MUSCLE, SKELETAL; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU;

EID: 0036810873     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35418     Document Type: Article

References (35)

1. Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptors. Trends Pharmacol Sci 1987; 8: 456-459
2. Khawaja XZ, Green IC, Thorpe JR, Titheradge MA. The occurrence and receptor specificity of endogenous opioid peptides with pancreas and liver of the rat. Comparison with brain. Biochem J 1990; 267: 233-240
3. Locatelli A, Spotti D, Caviezel F. The regulation of insulin and glucagon secretion by opiates: A study with naloxone in healthy humans. Acta Diabetol 1985; 22: 25-31
4. Curry DL, Bennett LL, Li CH. Stimulation of insulin secretion by beta-endorphins (1-27 & 1-31). Life Sci 1987; 40: 2053-2058
5. Liu IM, Niu CS, Chi TC, Kuo DH, Cheng JT. Investigations of the mechanism of the reduction of plasma glucose by cold-stress in streptozotocin-induced diabetic rats. Neurosci 1999; 92: 1137-1142
6. Cheng JT, Liu IM, Chi TC, Tzeng TF. Release of beta-endorphin by prostaglandin E2 to lower plasma glucose in streptozotocin-induced diabetic rats. Horm Metab Res 2001; 33: 439-443
7. Liu IM, Chi TC, Chen YC, Lu FH, Cheng JT. Activation of opioid μ-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett 1999; 265: 183-186
8. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucoselowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 2815-2821
9. Asakawa A, Inui A, Ueno N, Fujimiya M, Fujino MA, Kasuga M. Endomorphin-1, an endogenous mu-opioid receptor-selective agonist, stimulates oxygen consumption in mice. Horm Metab Res 2000; 32; 51-52
10. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661-665
11. Katz A, Wu D, Simon MI. Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature 1993: 360: 686-689
12. Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophy Acta 1993; 1179: 171-188
13. Ishizuka T, Cooper DR, Hernandez H, Buckley D, Standaert M, Farese RV. Effects of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationship to glucose transport. Diabetes 1990; 39: 181-190
14. Van Epps-Fung M, Gupta K, Hardy RW, Wells A. A role for phospholipase C activity in GLUT4-Mediated glucose transport. Endocrinology 1997; 138: 5170-5175
15. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. Opioid μ receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Mol Brain Res 1998; 54: 321-326
16. Liu IM, Chi TC, Shiao GC, Lin MT, Cheng JT. Loss of plasma glucose lowering response to cold stress in opioid μ-receptor knock-out diabetic mice. Neurosci Lett 2001; 307: 81-84
17. Liu IM, Hsu FL, Chen CF, Cheng JT. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br J Pharmacol 2000; 129: 631-636
18. Fry JR, Jones CA, Wiebkin P, Bellemann P, Bridges JW. The enzymic isolation of adult rat hepatocytes in a functional and viable state. Analyt Biochem 1976; 71: 341-350
19. Agius L, Peak M, Alberti KG. Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem J 1990; 266: 91-102
20. Martin WR. Opioid antagonists. Pharmacol Rev 1967; 19: 463-521
21. Ling GSF, Simantov R, Clark JA, Pasternak GW. Naloxonazine actions in vivo. Eur J Pharmacol 1986; 129: 33-38
22. Baron AD, Brechtel G, Wallace P, Edelman SV. Rates and tissue sites of non-insulin-and insulin-mediated glucose uptake in human. Am J Physiol 1988; 255: E769-E774
23. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998; 336: 1-31
24. Ploug TH, Galbo H, Richter EA. Increased muscle glucose uptake during contractions: No need for insulin. Am J Physiol 1984; 247: E726-E731
25. 3 rat pituitary cell. Endocrinology 1992; 131: 1883-1888
26. Muto Y, Nagao T, Urushidani T. The putative phospholipase C inhibitor U73122 and its negative control, U73343, elicit unexpected effects on the rabbit parietal cell. J Pharmac Exp Ther 1997; 282: 1379-1388
27. 12 cells. Naunyn-Schmiedebergs Arch Pharmacol 2000; 362: 122-127
28. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990; 172: 993-999
29. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudent V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991; 266: 15771-15781
30. Cheng JT, Liu IM, Chi TC, Shinozuka K, Lu FH, Wu TJ, Chang CJ. Role of adenosine in insulin-stimulated release of leptin from isolated white adipocytes of Wistar rats. Diabetes 2000; 49: 20-24
31. Liu JP. Protein kinase C and its substrates. Mol Cell Endo 1996; 116: 1-29
32. Mayer DJ, Mao J, Price DD. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 1995; 61: 365-374
33. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H, Yu L. The human mu opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 1995; 15: 2396-2406
34. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB. Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 1996; 271: 11449-11454
35. Yu L. Protein kinase modulation of mu opioid receptor signaling. Cell Signal 1996; 8: 371-374